- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.94%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option and its peers as on 27 March, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth Plan-Growth Option | -2.67% | -0.94% | -0.28% | -3.79% | -2.66% | 2.84% | 22.59% | 15.28% | 18.71% | 14.04% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 0.55% | 1.53% | 0.72% | -1.75% | 0.14% | 1.62% | 25.71% | 17.69% | 20.08% | 11.98% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -12.73% | -2.24% | -0.96% | -10.63% | -12.2% | -4.03% | 11.57% | 10.03% | 11.14% | 11.59% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -10.65% | -2.07% | -2.18% | -9.57% | -9.95% | -3.66% | 17.67% | 18.43% | 16.97% | 15.43% |
| SBI PSU Fund - REGULAR PLAN -Growth | -2.43% | -1.52% | -2.45% | -10.58% | -0.43% | 10.78% | 31.38% | 26.04% | 18.13% | 14.89% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -13.17% | -2.07% | -1.11% | -8.78% | -13.32% | -9.91% | 10.43% | 14.14% | 12.43% | 13.66% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -10.27% | 7.14% | 3.79% | 2.14% | 67.04% | 22.66% | -10% | 40.12% | 34.25% | -3.81% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 1.34% | 2.92% | 2.59% | -1.48% | -2.59% | 2.16% | 0.82% | -1.31% | -4.73% | 5.23% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 11.13% | -3.28% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.67% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.33% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.67% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.07% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 7.26% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 6.29% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.97% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 5.62% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 3.42% |
| MedPlus Health Services Limited | MEDPLUS (INE804L01022) | Retailing | 3.32% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 3.05% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 2.87% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 2.83% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.81% |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 2.59% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.39% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.32% |
| Dr. Lal Path Labs Limited | LALPATHLAB (INE600L01024) | Healthcare Services | 2.29% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.16% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.14% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 2.10% |
| JB Chemicals & Pharmaceuticals Limited | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.01% |
| Pfizer Limited | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.99% |
| Narayana Hrudayalaya Limited | NH (INE410P01011) | Healthcare Services | 1.95% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.50% |
| Suraksha Diagnostic Limited | SURAKSHA (INE877V01027) | Healthcare Services | 1.48% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 1.35% |
| Sanofi India Limited | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 1.32% |
| Sanofi Consumer Healthcare India Limited | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.24% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 1.23% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 1.00% |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.90% |
| Akums Drugs and Pharmaceuticals Limited | AKUMS (INE09XN01023) | Pharmaceuticals & Biotechnology | 0.84% |
| Emcure Pharmaceuticals Limited | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 0.74% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 0.72% |
| Indoco Remedies Limited | INDOCO (INE873D01024) | Pharmaceuticals & Biotechnology | 0.61% |
| Orchid Pharma Limited | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.43% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 0.19% |
Portfolio data is as on date 31 October, 2025
NAV history
Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 27 March, 2026 | 495.6005 | -0.94% |
| 25 March, 2026 | 500.3119 | 1.57% |
| 24 March, 2026 | 492.5647 | 1.16% |
| 23 March, 2026 | 486.9288 | -2.03% |
| 20 March, 2026 | 497.0102 | 1.12% |
| 19 March, 2026 | 491.5207 | -2.26% |
| 18 March, 2026 | 502.8705 | 0.54% |
| 17 March, 2026 | 500.1613 | 0.32% |
| 16 March, 2026 | 498.5491 | -0.9% |
| 13 March, 2026 | 503.0646 | -1.79% |
| 12 March, 2026 | 512.2375 | -0.4% |
| 11 March, 2026 | 514.3193 | 0.15% |
| 10 March, 2026 | 513.5237 | 0.85% |
| 9 March, 2026 | 509.2156 | -0.29% |
| 6 March, 2026 | 510.6854 | -0.25% |
| 5 March, 2026 | 511.9517 | 1.19% |
| 4 March, 2026 | 505.9395 | -1.35% |
| 2 March, 2026 | 512.8559 | -0.44% |
| 27 February, 2026 | 515.0993 | -0.89% |
| 26 February, 2026 | 519.7215 | 0.78% |
| 25 February, 2026 | 515.6756 | 1.36% |
| 24 February, 2026 | 508.7531 | -0.24% |
| 23 February, 2026 | 509.9770 | 0.81% |
| 20 February, 2026 | 505.8782 | -0.03% |
| 19 February, 2026 | 506.0229 | -0.54% |
| 18 February, 2026 | 508.7629 | 0.01% |
| 17 February, 2026 | 508.7330 | 0.5% |
| 16 February, 2026 | 506.1920 | 0.73% |
| 13 February, 2026 | 502.5126 | -0.79% |
| 12 February, 2026 | 506.5367 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 495.6005 as on 27 March, 2026.What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are -2.67% as on 27 March, 2026.What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 2.84% as on 27 March, 2026.What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 22.59% as on 27 March, 2026.What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 15.28% as on 27 March, 2026.What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 15.28% as on 27 March, 2026.